Showing results (501-510 of 1,350) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|June 30, 2021
Bioequivalence for a Fixed-Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given TogetherJae Nam Yun, Hye-Su Kan, Ji-Sun Yeun, et al.
Clinical Pharmacology in Drug Development|June 19, 2021
Effects of Itraconazole and Rifampin on the Pharmacokinetics of Mobocertinib (TAK-788), an Oral Epidermal Growth Factor Receptor Inhibitor, in Healthy VolunteersSteven Zhang, Shu Jin, Celina Griffin, et al.
Clinical Pharmacology in Drug Development|December 19, 2022
Pharmacokinetic and Pharmacologic Characterization of the Dihydrotetrabenazine Isomers of Deutetrabenazine and ValbenazineSatjit Brar, Arjun Vijan, Fiona L Scott, et al.
Clinical Pharmacology in Drug Development|December 2, 2022
Bioequivalence and Pharmacokinetic Profiles of 2 Trimetazidine Modified-release Tablets Under Fasting and Fed Conditions in Chinese Healthy SubjectsJue Wang, Yuanying Yang, Xiaomei Huang, et al.
Clinical Pharmacology in Drug Development|December 2, 2022
A Food-Effect Study to Evaluate the Oral Bioavailability of DesidustatHardik Patel, Taufik Momin, Kevinkumar Kansagra, et al.
Clinical Pharmacology in Drug Development|December 5, 2022
Pharmacokinetic, Safety, and Tolerability Evaluations of Gepotidacin (GSK2140944) in Healthy Japanese ParticipantsAline Barth, Mohammad Hossain, Caroline R Perry, et al.
Clinical Pharmacology in Drug Development|September 18, 2020
Pharmacokinetics, Safety, and Tolerability of Single- and Multiple-Dose Once-Daily Baricitinib in Healthy Chinese Subjects: A Randomized Placebo-Controlled StudyXia Zhao, Xiao Yan Sheng, Christopher D Payne, et al.
Clinical Pharmacology in Drug Development|September 24, 2020
First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase ModulatorYing Ye, Allison Gaudy, Peter Schafer, et al.
Clinical Pharmacology in Drug Development|October 8, 2020
Safety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator (D1PAM), in Healthy SubjectsDarren Wilbraham, Kevin M Biglan, Kjell A Svensson, et al.
Clinical Pharmacology in Drug Development|December 28, 2020
Pharmacokinetics and Safety of Glasdegib in Participants With Moderate/Severe Hepatic Impairment: A Phase I, Single-Dose, Matched Case-Control StudyJoanna C Masters, Robert R LaBadie, Joanne Salageanu, et al.
Pageof 135